Bone Density Decline: Tenofovir has been related to a decrease in bone mineral density, expanding the potential risk of bone troubles or fractures.In phase three scientific trials, tenofovir offered an identical efficacy than efavirenz in remedy-naive HIV people. In hepatitis B infected patients, just after a person 12 months of tenofovir treatment